Homozygous coding mutations in PMM2 have been previously reported to cause a congenital disorder of glycosylation type 1a, a severe multisystem disease with prominent neurologic features which were not observed in patients with the promoter mutation. The gene discussed is PMM2; the disease is PMM2-congenital disorder of glycosylation.